Dergiler / Molecular Oncologic Imaging
Molecular Oncologic Imaging
The publication language of the journal: English Online ISSN: 2791-965X The journal is peer-review-double blind periodical journal and the interest areas are Nuclear Medicine, Radiology and Radiation Oncology in the field of Oncology. The journal covers the articles about the included fields and will focus on innovations and new developments. All the articles about Imaging in Oncology will be accepted in case of including new advances. The main topic of this journal is Oncologic Imaging and the journal will accept articles (original, case reports as well as review articles) in all the fields (Nuclear Medicine, Radiation Oncology and Radiology) about Oncologic Imaging. The Ethics standards of this publications include; the publication rights and permissions of the articles are preserved by the Journal. The authors should provide the data of the article for the reference for a reasonable time period. Also the authors are responsible to check for plagiarism and should provide original data. The manuscript that is submitted to journal should not be under consideration of another journal and-or not published previously except for publications as an abstract for a scientific meeting. The suitable citations are in the responsibility of the corresponding author as well as the special permissions for the sources of the published visual materials (Tables, graphics, images) in case of external use. The coauthors of the article should participate sufficiently to the publication proses and approve of the last version of the manuscript before publication. If the publication includes human or animal subjects the authors should verify the rules and regulations are followed during the preparation of the article and the study was confirmed by an Ethics Committee. All the manuscript should include a financial disclosure and conflict of interest section and acknowledgements should be stated after the conclusion before the references. Three times a year.
2022 · Cilt: 2 - Sayı: 2
| Makale | Yazar | Sayfa |
|---|---|---|
| Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography | Zehra Pınar KOÇ, Pınar Pelin ÖZCAN, Nurdan ORUÇOĞLU, Hamide SAYAR | 1–5 |
| Coincident Pelvic Uptake in the F-18 FDG PET/CT Imaging in Patients With the Diagnosis of Breast Carcinoma | Zehra Pınar KOÇ, Pınar Pelin ÖZCAN, Emel SEZER, Ahmet DAĞ, Ferah TUNCEL DALOĞLU, Tolgay Tuyan İLHAN | 6–11 |
| Metastatic Brain Lesions of Colon Carcinoma on F-18 Fluorodeoxyglucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) | Zehra Pınar KOÇ, Hamide SAYAR | 12–14 |
| Ga-68 PSMA PET-CT in Initial Staging First Line Imaging of Prostate Cancer: The Clinical Impact of Oligometastatic Disease | Pınar Pelin ÖZCAN, Zehra Pınar KOÇ, Vehbi ERÇOLAK, Zeynep Selcan SAĞLAM, Gökçe YAVAN, Murat BOZLU, Mesut TEK, Erdem AKBAY | 15–24 |
| Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma | Gökçe YAVAN, Zehra Pınar KOÇ, Pınar Pelin ÖZCAN | 25–26 |